Matches in SemOpenAlex for { <https://semopenalex.org/work/W2617856138> ?p ?o ?g. }
- W2617856138 endingPage "e6531" @default.
- W2617856138 startingPage "e6531" @default.
- W2617856138 abstract "Background: Polyunsaturated fats (PUFAs) have been shown to reduce type 2 diabetes (T2DM) risk and improve insulin responsiveness in T2DM subjects, but whether the plant sources of omega-3 PUFA (alpha-linolenic acid [ALA]) have an effect on glycemic control requires further investigation. Methods: The parameters of interest were glycated hemoglobin (HbA1c), fasting blood glucose (FBG), fasting blood insulin (FBI), homeostatic model assessment for insulin resistance (HOMA-IR), fructosamine, and glycated albumin. A comprehensive search was conducted with MEDLINE, Embase, CINAHL, and Cochrane. Eligible studies included randomized controlled trials (RCTs) ≥1 month in duration that compared diets enriched in ALA with usual diets on glycemic parameters. For each study, the risk of bias as well as the study quality was assessed. Using the statistical software RevMan (v5.3), data were pooled using the generic inverse method with random effects model, and final results were expressed as mean differences (MD) with 95% confidence intervals (CI). Heterogeneity was assessed by the Cochran Q statistic and quantified by the I2 statistic. Results: A total of 8 trials (N = 212) were included in the meta-analysis. Compared to a control diet, a median dose of 4.4 g/day of ALA intake for a median duration of 3 months did not affect HbA1c (%) (MD = –.01; [95%: –.32, .31], P = .96). A median ALA dose of 5.4 g/day did not lower FBG (MD = .07; [95% CI: –.61, .76], P = .84) or FBI (MD = 7.03, [95% CI: –5.84, 19.89], P = .28). Summary effect estimates were generally compromised by considerable and unexplained heterogeneity (I2 ≥75%). In the subgroup analysis of continuous predictors, a reduction in HbA1c (%) and FBG (mmol/L) was significantly associated with an increased intake of ALA. Further adjustment for Publication Bias using Duval and Tweedie's trim-and-fill analysis provided an adjusted, significant MD of –.25 (95% CI: –.38, –.12; P <.001) for HbA1c (%). Conclusions: ALA-enriched diets did not affect HbA1c, FBG, or FBI. The scarce number of existing RCTs and the presence of heterogeneity in our meta-analysis limit the ability to make firm conclusions about ALA in T2DM management. The potential for ALA to have dose-dependent effects warrants further research in this area." @default.
- W2617856138 created "2017-06-05" @default.
- W2617856138 creator A5001516546 @default.
- W2617856138 creator A5015706008 @default.
- W2617856138 creator A5018880799 @default.
- W2617856138 creator A5025954705 @default.
- W2617856138 creator A5037078295 @default.
- W2617856138 creator A5037636324 @default.
- W2617856138 creator A5056312738 @default.
- W2617856138 creator A5066608875 @default.
- W2617856138 creator A5075736599 @default.
- W2617856138 creator A5091165772 @default.
- W2617856138 creator A5091496101 @default.
- W2617856138 date "2017-05-01" @default.
- W2617856138 modified "2023-10-16" @default.
- W2617856138 title "The effect of alpha-linolenic acid on glycemic control in individuals with type 2 diabetes" @default.
- W2617856138 cites W1827328405 @default.
- W2617856138 cites W1927294449 @default.
- W2617856138 cites W1963710347 @default.
- W2617856138 cites W1970956234 @default.
- W2617856138 cites W1975496553 @default.
- W2617856138 cites W1976886927 @default.
- W2617856138 cites W1978718896 @default.
- W2617856138 cites W1993299437 @default.
- W2617856138 cites W1996154720 @default.
- W2617856138 cites W1998098109 @default.
- W2617856138 cites W2000084601 @default.
- W2617856138 cites W2005530469 @default.
- W2617856138 cites W2007872832 @default.
- W2617856138 cites W2012325805 @default.
- W2617856138 cites W2021503045 @default.
- W2617856138 cites W2042511422 @default.
- W2617856138 cites W2046582440 @default.
- W2617856138 cites W2047885117 @default.
- W2617856138 cites W2066377757 @default.
- W2617856138 cites W2080560478 @default.
- W2617856138 cites W2082398379 @default.
- W2617856138 cites W2091429768 @default.
- W2617856138 cites W2093361164 @default.
- W2617856138 cites W2093983853 @default.
- W2617856138 cites W2096570619 @default.
- W2617856138 cites W2097226936 @default.
- W2617856138 cites W2100861855 @default.
- W2617856138 cites W2104285446 @default.
- W2617856138 cites W2105206504 @default.
- W2617856138 cites W2105716007 @default.
- W2617856138 cites W2114020589 @default.
- W2617856138 cites W2114493815 @default.
- W2617856138 cites W2130235475 @default.
- W2617856138 cites W2138703255 @default.
- W2617856138 cites W2145983281 @default.
- W2617856138 cites W2149548561 @default.
- W2617856138 cites W2151700012 @default.
- W2617856138 cites W2151821320 @default.
- W2617856138 cites W2153733216 @default.
- W2617856138 cites W2156271937 @default.
- W2617856138 cites W2156419944 @default.
- W2617856138 cites W2156747689 @default.
- W2617856138 cites W2158729167 @default.
- W2617856138 cites W2167179940 @default.
- W2617856138 cites W2172043580 @default.
- W2617856138 cites W2292502644 @default.
- W2617856138 cites W4211166190 @default.
- W2617856138 cites W4295849207 @default.
- W2617856138 doi "https://doi.org/10.1097/md.0000000000006531" @default.
- W2617856138 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5457843" @default.
- W2617856138 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28538363" @default.
- W2617856138 hasPublicationYear "2017" @default.
- W2617856138 type Work @default.
- W2617856138 sameAs 2617856138 @default.
- W2617856138 citedByCount "46" @default.
- W2617856138 countsByYear W26178561382018 @default.
- W2617856138 countsByYear W26178561382019 @default.
- W2617856138 countsByYear W26178561382020 @default.
- W2617856138 countsByYear W26178561382021 @default.
- W2617856138 countsByYear W26178561382022 @default.
- W2617856138 countsByYear W26178561382023 @default.
- W2617856138 crossrefType "journal-article" @default.
- W2617856138 hasAuthorship W2617856138A5001516546 @default.
- W2617856138 hasAuthorship W2617856138A5015706008 @default.
- W2617856138 hasAuthorship W2617856138A5018880799 @default.
- W2617856138 hasAuthorship W2617856138A5025954705 @default.
- W2617856138 hasAuthorship W2617856138A5037078295 @default.
- W2617856138 hasAuthorship W2617856138A5037636324 @default.
- W2617856138 hasAuthorship W2617856138A5056312738 @default.
- W2617856138 hasAuthorship W2617856138A5066608875 @default.
- W2617856138 hasAuthorship W2617856138A5075736599 @default.
- W2617856138 hasAuthorship W2617856138A5091165772 @default.
- W2617856138 hasAuthorship W2617856138A5091496101 @default.
- W2617856138 hasBestOaLocation W26178561381 @default.
- W2617856138 hasConcept C126322002 @default.
- W2617856138 hasConcept C134018914 @default.
- W2617856138 hasConcept C168563851 @default.
- W2617856138 hasConcept C2777180221 @default.
- W2617856138 hasConcept C2777391703 @default.
- W2617856138 hasConcept C2777538456 @default.
- W2617856138 hasConcept C2779306644 @default.
- W2617856138 hasConcept C2780473172 @default.